Business
Novartis Sees Sales Growth Through 2031
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: WSJ.com: US Business
The drugmaker expects annual sales growth of 5% from 2026 to 2031, from a previous forecast of 5% to 6% over the 2025-30 period.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at WSJ.com: US Business



